Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Cy3 TSA Fluorescence System Kit: Elevating Signal Amplifi...

    2026-01-06

    Cy3 TSA Fluorescence System Kit: Elevating Signal Amplification in IHC

    Introduction: The Next Frontier in Fluorescence Microscopy Detection

    In the era of precision research, the ability to detect low-abundance proteins and nucleic acids is pivotal for advancing our understanding of disease mechanisms and developing targeted therapies. Conventional immunohistochemistry (IHC), immunocytochemistry (ICC), and in situ hybridization (ISH) platforms often reach their limits when confronted with scarce or weakly expressed biomolecules. Enter the Cy3 TSA Fluorescence System Kit—a tyramide signal amplification kit that harnesses the power of HRP-catalyzed tyramide deposition to deliver robust, localized fluorescence amplification. Developed by APExBIO, this kit leverages the unique excitation/emission properties of Cy3 (excitation at 550 nm, emission at 570 nm), ensuring compatibility with standard fluorescence microscopy setups and delivering ultra-sensitive detection in both fundamental and translational research settings.

    Principle of the Cy3 TSA Fluorescence System Kit

    The core of the Cy3 TSA Fluorescence System Kit is tyramide signal amplification (TSA), a technique designed to overcome the sensitivity barriers of traditional fluorescence labeling. The workflow capitalizes on horseradish peroxidase (HRP)-conjugated secondary antibodies, which catalyze the conversion of Cy3-labeled tyramide into a highly reactive intermediate. This intermediate rapidly and covalently binds to tyrosine residues in close proximity to the target antigen or nucleic acid, resulting in a dense, localized Cy3 signal.

    • Signal Amplification in Immunohistochemistry: TSA technology enhances sensitivity by up to 100-fold compared to conventional methods, enabling visualization of targets previously undetectable due to low abundance [1].
    • HRP-Catalyzed Tyramide Deposition: The enzymatic reaction ensures specific, localized deposition of the Cy3 fluorophore, minimizing background and maximizing contrast for clear, quantitative imaging.
    • Fluorophore Cy3 Excitation/Emission: With excitation at 550 nm and emission at 570 nm, Cy3 provides a bright, photostable signal compatible with standard filter sets.

    This high-density fluorescent labeling is particularly advantageous for studies requiring detection of low-abundance molecules, as seen in cancer research or epigenetic profiling.

    Step-by-Step Workflow and Protocol Enhancements

    1. Sample Preparation

    • Fix tissue or cell samples using paraformaldehyde or formalin to preserve morphology and antigenicity.
    • Permeabilize cells/tissues (e.g., with Triton X-100) to facilitate antibody and tyramide access.
    • Perform antigen retrieval as necessary, especially for formalin-fixed, paraffin-embedded (FFPE) samples.

    2. Blocking

    • Apply the kit's proprietary Blocking Reagent (store at 4°C) to minimize non-specific binding.

    3. Primary and Secondary Antibody Incubation

    • Incubate with a well-validated primary antibody (or probe for ISH applications) targeting the protein or nucleic acid of interest.
    • Apply an HRP-conjugated secondary antibody compatible with your primary antibody's host species.

    4. Tyramide Signal Amplification

    • Prepare Cy3-tyramide working solution by dissolving the dry Cyanine 3 Tyramide in DMSO, then dilute with Amplification Diluent just before use. Protect from light and store at –20°C for optimal stability (up to 2 years).
    • Incubate samples with the Cy3-tyramide solution, allowing HRP to catalyze the deposition of Cy3 at target sites. Typical incubation times range from 5–15 minutes, depending on the abundance of the target.

    5. Washing and Mounting

    • Thoroughly wash samples with PBS or TBS to remove unbound reagents and reduce background.
    • Mount using an anti-fade medium compatible with Cy3 to preserve fluorescence signal for imaging.

    6. Imaging

    • Image samples using a fluorescence microscope with filter sets suitable for Cy3 (excitation 550 nm, emission 570 nm).
    • Adjust exposure settings to avoid signal saturation due to the high amplification power of TSA.

    Protocol Enhancements: Compared to conventional immunofluorescence, the Cy3 TSA kit’s amplification step enables detection of targets at concentrations as low as picograms per milliliter, with reported signal-to-noise improvements of 10- to 100-fold [2]. This makes it ideal for challenging applications such as regulatory RNA mapping or single-cell protein profiling.

    Advanced Applications and Comparative Advantages

    Detection of Low-Abundance Biomolecules in Cancer Research

    A recent study by Li et al. (Advanced Science, 2024) underscores the importance of quantifying low-level gene and protein expression in cancer. The authors dissected the transcriptional control of de novo lipogenesis in liver cancer, focusing on the SIX1 transcription factor and its downstream targets, including SCD1 and FASN. Such research demands ultra-sensitive detection methods. The Cy3 TSA Fluorescence System Kit empowers scientists to visualize these rare targets in situ, capturing spatial relationships that are otherwise lost with bulk methods.

    Immunocytochemistry Fluorescence Amplification for Epigenetics and Non-Coding RNA

    The kit enables robust detection of lncRNAs, miRNAs, or chromatin-associated factors—molecules often expressed at low or transient levels. As highlighted in "Cy3 TSA Fluorescence System Kit: Amplifying lncRNA and Signaling Pathways", researchers can extend their reach beyond protein markers to regulatory RNAs, capturing nuanced regulatory events in developmental biology, neurobiology, and oncology.

    In Situ Hybridization Signal Enhancement

    The Cy3 TSA kit’s compatibility with ISH workflows enables high-resolution mapping of mRNA, lncRNA, or even viral genomes in fixed tissues. This is especially valuable for studies dissecting cell-type–specific gene expression patterns within complex tissues, such as tumors or developing organs.

    Comparative Advantages Over Conventional Methods

    • Superior Sensitivity: Detects targets undetectable by standard fluorophore-conjugated antibodies.
    • Multiplexing Capacity: TSA-based detection allows for sequential labeling and stripping, facilitating multi-target analysis in a single specimen.
    • Photostability and Specificity: Covalent deposition of Cy3 ensures signal retention and minimal photobleaching, with low background owing to precise HRP localization.
    • Broad Compatibility: Works with standard fluorescence microscopy setups and complements RNA/protein co-detection protocols.

    For an in-depth look at how TSA-based amplification stands apart from standard detection, see "Cy3 TSA Fluorescence System Kit: Transforming Signal Amplification", which contrasts the kit’s performance profile with conventional immunofluorescence, particularly in translational studies.

    Troubleshooting and Optimization Tips

    • High Background Signal: Ensure thorough blocking and optimize antibody concentrations. Excessive HRP levels can increase non-specific tyramide deposition; titrate secondary antibody as needed.
    • Weak or Absent Signal: Confirm activity of primary and secondary antibodies. Verify proper storage and reconstitution of Cy3 tyramide. Shorten washing steps to minimize loss of loosely bound targets.
    • Photobleaching: Use anti-fade mounting media and minimize exposure during imaging. Cy3 is photostable, but intense illumination can still reduce signal over time.
    • Multiplex Staining: To avoid channel cross-talk, fully quench HRP activity before introducing subsequent tyramide-conjugates of different colors. Carefully validate filter sets for clean spectral separation.
    • Storage and Handling: Protect Cy3 tyramide from light and store at –20°C. Use freshly prepared working solutions for best results. Amplification Diluent and Blocking Reagent should be kept at 4°C.

    For more troubleshooting insights, consult "Cy3 TSA Fluorescence System Kit: Ultra-Sensitive Signal Amplification", which offers a comprehensive troubleshooting guide and real-world case studies.

    Future Outlook: Expanding the Toolkit for Protein and Nucleic Acid Detection

    As research pivots toward single-cell analysis, spatial transcriptomics, and high-content screening, demand for ultra-sensitive, multiplexed detection platforms will only intensify. The Cy3 TSA Fluorescence System Kit, available from APExBIO, is poised to play a crucial role in these next-generation workflows by enabling high-fidelity signal amplification in immunohistochemistry, immunocytochemistry, and in situ hybridization.

    Emerging applications include:

    • Spatial Multi-Omic Profiling: Integrating TSA-based fluorescence amplification with imaging mass cytometry or spatial transcriptomics for comprehensive tissue analysis.
    • Advanced Cancer Biomarker Discovery: Detecting rare cancer stem cell markers, regulatory RNAs, or pathway-specific proteins within heterogeneous tumor microenvironments.
    • Clinical Translation: While currently for research use only, the kit’s robust performance is informing the development of clinical-grade diagnostics for minimal residual disease and personalized medicine.

    In sum, the Cy3 TSA Fluorescence System Kit sets a new standard for signal amplification in fluorescence microscopy, empowering researchers to push the boundaries of protein and nucleic acid detection. As evidenced by both peer-reviewed studies such as Li et al. and expert reviews [1], APExBIO’s commitment to innovation is driving the next wave of discovery in the life sciences.